Literature DB >> 26406984

Clinical significance of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level and high-sensitivity C-reactive protein concentration in autoimmune hepatitis.

Hiroki Nishikawa1, Hirayuki Enomoto1, Yoshinori Iwata1, Kunihiro Hasegawa1, Chikage Nakano1, Ryo Takata1, Takashi Nishimura1, Kazunori Yoh1, Nobuhiro Aizawa1, Yoshiyuki Sakai1, Naoto Ikeda1, Tomoyuki Takashima1, Hiroko Iijima1, Shuhei Nishiguchi1.   

Abstract

AIM: We aimed to examine the relationship between the Wisteria floribunda agglutinin positive Mac-2-binding protein (WFA(+) -M2BP) level and high-sensitivity C-reactive protein (hCRP) concentration and liver histological findings for patients with autoimmune hepatitis (AIH).
METHODS: A total of 84 AIH patients (median age, 64 years) were analyzed. We examined the effect of pretreatment WFA(+) -M2BP level and hCRP concentration on histological findings of liver fibrosis and liver inflammation activity comparing with other laboratory markers. Receiver-operator curve (ROC) analysis was performed for calculating the area under the ROC (AUROC).
RESULTS: The median WFA(+) -M2BP values in each fibrosis stage were: 1.5 cut-off index (COI) in F1, 2.1 in F2, 3.3 in F3 and 9.8 in F4 (P < 0.001). The median WFA(+) -M2BP values in each liver inflammation stage were: 1.6 COI in A1, 2.5 in A2 and 5.4 in A3 (P < 0.001). For predicting liver cirrhosis (F4), WFA(+) -M2BP yielded the highest AUROC (0.853). For predicting advanced liver fibrosis (F3 or F4), WFA(+) -M2BP, FIB-4 index and hyaluronic acid yielded the highest AUROC (0.747). For predicting severe liver inflammation activity (A3), WFA(+) -M2BP yielded the highest AUROC (0.739). The hCRP concentration in patients with A3 (median, 2230 ng/mL) was significantly higher than that in patients with A1 or A2 (median, 854.5 ng/mL) (P < 0.01). WFA(+) -M2BP level significantly correlated with hCRP concentration (rs  = 0.461, P < 0.001).
CONCLUSION: WFA(+) -M2BP can be a useful marker for assessing liver histological findings in AIH patients and it correlated well with hCRP concentration.
© 2015 The Japan Society of Hepatology.

Entities:  

Keywords:  Wisteria floribunda agglutinin positive Mac-2-binding protein; autoimmune hepatitis; high-sensitivity C-reactive protein; inflammation activity; liver fibrosis

Year:  2015        PMID: 26406984     DOI: 10.1111/hepr.12596

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  31 in total

Review 1.  Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis.

Authors:  Ken Shirabe; Yuki Bekki; Dolgormaa Gantumur; Kenichiro Araki; Norihiro Ishii; Atsushi Kuno; Hisashi Narimatsu; Masashi Mizokami
Journal:  J Gastroenterol       Date:  2018-01-09       Impact factor: 7.527

Review 2.  Hyaluronan in immune dysregulation and autoimmune diseases.

Authors:  Nadine Nagy; Hedwich F Kuipers; Payton L Marshall; Esther Wang; Gernot Kaber; Paul L Bollyky
Journal:  Matrix Biol       Date:  2018-04-04       Impact factor: 11.583

3.  Hyaluronan levels are increased systemically in human type 2 but not type 1 diabetes independently of glycemic control.

Authors:  Nadine Nagy; Vivekananda G Sunkari; Gernot Kaber; Sonia Hasbun; Dung N Lam; Cate Speake; Srinath Sanda; Tracey L McLaughlin; Thomas N Wight; Steven R Long; Paul L Bollyky
Journal:  Matrix Biol       Date:  2018-09-06       Impact factor: 11.583

4.  Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts hepatocellular carcinoma incidence and recurrence in nucleos(t)ide analogue therapy for chronic hepatitis B.

Authors:  Kazunori Kawaguchi; Masao Honda; Hajime Ohta; Takeshi Terashima; Tetsuro Shimakami; Kuniaki Arai; Taro Yamashita; Yoshio Sakai; Tatsuya Yamashita; Eishiro Mizukoshi; Takuya Komura; Masashi Unoura; Shuichi Kaneko
Journal:  J Gastroenterol       Date:  2017-08-28       Impact factor: 7.527

5.  Increased serum Wisteria floribunda agglutinin positive Mac-2 binding protein (Mac-2 binding protein glycosylation isomer) in chronic heart failure: a pilot study.

Authors:  Atsushi Okada; Hideaki Kanzaki; Yasuhiro Hamatani; Seiji Takashio; Hiroyuki Takahama; Makoto Amaki; Takuya Hasegawa; Yasuo Sugano; Satoshi Yasuda; Toshihisa Anzai
Journal:  Heart Vessels       Date:  2017-11-02       Impact factor: 2.037

6.  Clinical implications of serum Mac-2-binding protein (M2BPGi) during regular follow-up of patients with biliary atresia.

Authors:  Takehisa Ueno; Tasuku Kodama; Yuki Noguchi; Ryuta Saka; Yuichi Takama; Yuko Tazuke; Kazuhiko Bessho; Hiroomi Okuyama
Journal:  Pediatr Surg Int       Date:  2018-08-20       Impact factor: 1.827

7.  M2BPGi as a potential diagnostic tool of cirrhosis in Chinese patients with Hepatitis B virus infection.

Authors:  Bin Wei; Shu Feng; Enqiang Chen; Dongdong Li; Tingting Wang; Yu Gou; Tingting Yang; Dongmei Zhang; Chuanmin Tao; Hong Tang
Journal:  J Clin Lab Anal       Date:  2017-05-24       Impact factor: 2.352

8.  Serum Biomarkers for Autoimmune Hepatitis Type 1: the Case for CD48 and a Review of the Literature.

Authors:  Mingli Hu; Zhengrui You; You Li; Bingyuan Huang; Nana Cui; Rui Wang; Yiran Wei; Bo Li; Jubo Liang; Qiaoyan Liu; Yikang Li; Hanxiao Wang; Qiwei Qian; Jun Zhang; Ruiling Chen; Zhuwan Lyu; Yong Chen; Xiao Xiao; Min Lian; Ruqi Tang; Qi Miao; Qixia Wang; Xiong Ma
Journal:  Clin Rev Allergy Immunol       Date:  2022-06-03       Impact factor: 8.667

9.  Early detection of liver fibrosis with serum Mac-2 binding protein glycosylation-modified isomer (M2BPGi) during follow-up intestinal failure patients without intestinal failure-associated liver disease (IFALD).

Authors:  Takehisa Ueno; Koki Takase; Koichi Deguchi; Kazunori Masahata; Motonari Nomura; Miho Watanabe; Masafumi Kamiyama; Yuko Tazuke; Kazuhiko Bessho; Hiroomi Okuyama
Journal:  Pediatr Surg Int       Date:  2022-09-20       Impact factor: 2.003

10.  Impact of Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein in Patients with Hepatitis C Virus-Related Compensated Liver Cirrhosis.

Authors:  Kunihiro Hasegawa; Ryo Takata; Hiroki Nishikawa; Hirayuki Enomoto; Akio Ishii; Yoshinori Iwata; Yuho Miyamoto; Noriko Ishii; Yukihisa Yuri; Chikage Nakano; Takashi Nishimura; Kazunori Yoh; Nobuhiro Aizawa; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Hiroko Iijima; Shuhei Nishiguchi
Journal:  Int J Mol Sci       Date:  2016-09-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.